Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...

Sidra Medicine, a member of Qatar Foundation, has established a gene therapy centre to treat rare genetic diseases such as ...

The announcement was made at Arab Health 2025 where Sidra Medicine will highlight its international patient service programmes ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

Patients with spinal muscular atrophy (SMA) type 2 showed improved motor ability when treated with intrathecal onasemnogene abeparvovec, an investigational gene therapy. “Maintaining motor ...

(Image Credits: Pixabay) The Central Board of Indirect Taxes and Customs (CBIC) has issued a notification stating that no Goods and Service Tax (GST) will be levied on gene therapy and it would be ...

Novartis is on the final straight to approval of its spinal muscular atrophy (SMA) gene therapy Zolgensma in the EU, after getting a recommendation for approval from the CHMP. The positive opinion ...

Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle ...

How a tiny spinal implant could help those with muscle-wasting disease - Three people with a muscle-destroying disease got ...